Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CA19-9' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 166 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Karapetis, CS; Yip, D; Virik, K; Strickland, A; Ryder, K; Cowling, M; Harper, PG
      Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil inthe treatment of carcinoma of unknown primary site

      MEDICAL ONCOLOGY
    2. Kashiwagi, H; Kijima, H; Dowaki, S; Ohtani, Y; Tobita, K; Yamazaki, H; Nakamura, M; Ueyama, H; Tanaka, M; Inokuchi, S; Makuuchi, H
      MUC1 and MUC2 expression in human gallbladder carcinoma: A clinicopathological study and relationship with prognosis

      ONCOLOGY REPORTS
    3. Akagi, J; Takai, E; Tamori, Y; Nakagawa, K; Ogawa, M
      CA19-9 epitope a possible marker for MUC-1/Y protein

      INTERNATIONAL JOURNAL OF ONCOLOGY
    4. Gaspar, MJ; Arribas, I; Coca, MC; Diez-Alonso, M
      Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma

      TUMOR BIOLOGY
    5. Nakagoe, T; Sawai, T; Tsujia, T; Jibiki, M; Ohbatake, M; Nanashima, A; Yamaguchi, H; Yasutake, T; Ayabe, H; Arisawa, K
      Prognostic value of serum sialyl Lewis(a), sialyl Lewis(x) and sialyl Tn antigens in blood from the tumor drainage vein of colorectal cancer patients

      TUMOR BIOLOGY
    6. Zheng, CX; Zhan, WH; Zhao, JZ; Zheng, D; Wang, DP; He, YL; Zheng, ZQ
      The prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer

      WORLD JOURNAL OF GASTROENTEROLOGY
    7. Nakagoe, T; Sawai, T; Tsuji, T; Jibiki, MA; Nanashima, A; Yamaguchi, H; Kurosaki, N; Yasutake, T; Ayabe, H
      Circulating sialyl Lewis(x), sialyl Lewis(a), and sialyl Tn antigens in colorectal cancer patients: multivariate analysis of predictive factors for serum antigen levels

      JOURNAL OF GASTROENTEROLOGY
    8. Jadvar, H; Fischman, AJ
      Evaluation of pancreatic carcinoma with FDG PET

      ABDOMINAL IMAGING
    9. Shiozawa, K; Ishii, K; Mori, T; Takamura, N; Ikehara, T; Shinohara, M; Kawafune, T; Sumino, Y; Nonaka, H
      Heterochronous development of intrahepatic cholangiocellular carcinoma following hepatocellular carcinoma in a hepatitis B virus carrier

      INTERNAL MEDICINE
    10. Leu, KM; Zalupski, MM
      Chemotherapy for resectable and advanced pancreatic cancer - The Berlin/Rothenberg article reviewed

      ONCOLOGY-NEW YORK
    11. Furukawa, H; Iwata, R; Moriyama, N
      Growth rate of pancreatic adenocarcinoma: Initial clinical experience

      PANCREAS
    12. Nakagoe, T; Sawai, T; Tsuji, T; Jibiki, M; Nanashima, A; Yamaguchi, H; Yasutake, T; Ayabe, H; Arisawa, K; Ishikawa, H
      Pre-operative serum levels of sialyl Tn antigen predict liver metastasis and poor prognosis in patients with gastric cancer

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    13. Frena, A
      SPan-1 and exocrine pancreatic carcinoma. The clinical role of a new tumormarker

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    14. Forones, NM; Tanaka, M; Matos, D
      Relationship between mesenteric and peripheral blood levels of CA 19-9 in patients with colorectal cancer

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    15. Nakagoe, T; Sawai, T; Tsuji, T; Jibiki, M; Ohbatake, M; Nanashima, A; Yamaguchi, H; Kurosaki, N; Yasutake, T; Ayabe, H; Arisawa, K
      Increased serum level of sialyl Lewis(x) antigen in blood from the tumor drainage vein in patients with non-polypoid growth type of colorectal cancer

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    16. Ohno, T; Nakano, T; Abe, A; Sano, T; Niibe, Y; Oka, K
      Mucinous adenocarcinoma of bartholin eland treated with radiation therapy:a case report

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    17. Gebauer, G; Muller-Ruchholtz, W
      Carcinoembryonic antigen and CA19-9: Implications of quantitative marker measurement in tissues for prognosis of colorectal cancer

      CANCER DETECTION AND PREVENTION
    18. Nakagoe, T; Sawai, T; Tsuji, T; Jibiki, MA; Nanashima, A; Yamaguchi, H; Yasutake, T; Kurosaki, N; Ayabe, H; Arisawa, K
      Preoperative serum levels of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens as prognostic markers after curative resection for colorectal cancer

      CANCER DETECTION AND PREVENTION
    19. Tas, F; Aykan, F; Aydiner, A; Yasasever, V; Topuz, E
      Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    20. Cerwenka, H; Aigner, R; Bacher, H; Werkgartner, G; El-Shabrawi, A; Quehenberger, F; Mischinger, HJ
      Pancreatitis-associated protein (PAP) in patients with pancreatic cancer

      ANTICANCER RESEARCH
    21. Shimura, T; Tsutsumi, S; Hosouchi, Y; Kojima, T; Kon, Y; Yonezu, M; Kuwano, H
      Clinical significance of soluble form of HLA class I molecule in Japanese patients with pancreatic cancer

      HUMAN IMMUNOLOGY
    22. Sreejayan, N; Wittig, BM; Von Stillfried, N; Hennicke, MS; Meyer, G; Stieber, P; Lamerz, R; Von Ritter, C
      Human biliary mucin binds to E-selectin: a possible role in modulation of inflammation

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    23. Ishigami, S; Natsugoe, S; Hokita, S; Che, XM; Tokuda, K; Nakajo, A; Iwashige, H; Tokushige, M; Watanabe, T; Takao, S; Aikou, T
      Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    24. Ishizuka, D; Shirai, Y; Sakai, Y; Hatakeyama, K
      Colorectal carcinoma liver metastases: clinical significance of preoperative measurement of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels

      INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
    25. Ichihara, T; Nomoto, S; Takeda, S; Nagura, H; Sakamoto, J; Kondo, K; Horisawa, M; Nakao, A
      Clinical usefulness of the immunostaining of the tumor markers in pancreatic cancer

      HEPATO-GASTROENTEROLOGY
    26. Forones, NM; Mandowsky, SV; Lourenco, LG
      Serum levels of interleukin-2 and tumor necrosis factor-alpha correlate totumor progression in gastric cancer

      HEPATO-GASTROENTEROLOGY
    27. Marrelli, D; Pinto, E; De Stefano, A; De Manzoni, G; Farnetani, M; Garosi, L; Roviello, F
      Preoperative positivity of serum tumor markers is a strong predictor of hematogenous recurrence of gastric cancer

      JOURNAL OF SURGICAL ONCOLOGY
    28. Tsuruta, K; Okamoto, A; Egawa, N; Kamisawa, T; Karasawa, K; Takahashi, T
      Survival benefits of adjuvant chemotherapy with oral doxifluridine (5 '-DFUR) following radiotherapy in patients with unresectable pancreatic cancer

      JOURNAL OF SURGICAL ONCOLOGY
    29. Marrelli, D; Pinto, E; De Stefano, A; Farnetani, M; Garosi, L; Roviello, F
      Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patientswith resectable gastric cancer

      AMERICAN JOURNAL OF SURGERY
    30. Fireman, Z; Trosi, L; Kopelman, Y; Segal, A; Sternberg, A
      Helicobacter pylori: Seroprevalence and colorectal cancer

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    31. Watanabe, M; Chigusa, M; Takahashi, H; Nakamura, J; Tanaka, H; Ohno, T
      High level of CA19-9, CA50, and CEA-producible human cholangiocarcinoma cell line changes in the secretion ratios in vitro or in vivo

      IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
    32. Kashiwagi, H; Kijima, H; Dowaki, S; Ohtani, Y; Tobita, K; Tsukui, M; Tanaka, Y; Matsubayasi, H; Tsuchida, T; Yamazaki, H; Nakamura, M; Ueyama, Y; Tanaka, M; Tajima, T; Makuuchi, H
      DF3 expression in human gallbladder carcinoma: Significance for lymphatic invasion

      INTERNATIONAL JOURNAL OF ONCOLOGY
    33. Cerwenka, H; Uggowitzer, M; Bacher, H; Werkgartner, G; El-Shabrawi, A; Mischinger, HJ
      Bronchogenic cyst appearing as a hepatic mass

      ABDOMINAL IMAGING
    34. Kamoshida, S; Ogane, N; Yasuda, M; Muramatsu, T; Bessho, T; Kajiwara, H; Osamura, Y
      Immunohistochemical study of type-1 blood antigen expressions in thyroid tumors: The significance for papillary carcinomas

      MODERN PATHOLOGY
    35. Kajiume, T; Yoshimi, S; Kobayashi, K; Kataoka, N
      A case of malignant lymphoma in a patient with high levels of CA125 and CA19-9

      PEDIATRIC HEMATOLOGY AND ONCOLOGY
    36. Tanaka, N; Okada, S; Ueno, H; Okusaka, T; Ikeda, M
      The usefulness of serial changes in serum CA19-9 levels in the diagnosis of pancreatic cancer

      PANCREAS
    37. Stuckle, CA; Ibing, HP; Adamietz, IA
      Value of computed tomography and tumor markers in detection of recurrent rectal carcinoma after surgery and radiotherapy.

      TUMORDIAGNOSTIK & THERAPIE
    38. Giannini, E; Borro, P; Botta, F; Chiarbonello, B; Fasoli, A; Malfatti, F; Romagnoli, P; Testa, E; Risso, D; Lantieri, PB; Antonucci, A; Boccato, M; Milone, S; Testa, R
      Cholestasis is the main determinant of abnormal CA 19-9 levels in patientswith liver cirrhosis

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    39. Brockmann, J; Emparan, C; Hernandez, CA; Sulkowski, U; Dietl, KH; Menzel, J; Wolters, H; Glodny, B; Senninger, N
      Gallbladder bile tumor marker quantification for detection of pancreato-biliary malignancies

      ANTICANCER RESEARCH
    40. Halm, U; Rohde, N; Klapdor, R; Reith, HG; Thiede, A; Etzrodt, G; Mossner, J; Keller, T
      Improved sensitivity of fuzzy logic based tumor marker profiles for diagnosis of pancreatic carcinoma versus benign pancreatic disease

      ANTICANCER RESEARCH
    41. Makovitzky, J; Gotze, S
      Immunohistochemical investigation with carbohydrate monoclonal antibodies in cystic fibrosis

      ANTICANCER RESEARCH
    42. Nazli, O; Bozdag, AD; Tansug, T; Kir, R; Kaymak, E
      The diagnostic importance of CEA and CA 19-9 for the early diagnosis of pancreatic carcinoma

      HEPATO-GASTROENTEROLOGY
    43. Obayashi, Y; Fujita, J; Nishiyama, T; Yoshinouchi, T; Kamei, T; Yamadori, I; Hojo, S; Ohtsuki, Y; Hirashima, M; Takahara, J
      Role of carbohydrate antigens sialyl Lewis (a) (CA19-9) in bronchoalveolarlavage in patients with pulmonary fibrosis

      RESPIRATION
    44. Slesak, B; Harlozinska-Szmyrka, A; Knast, W; Sedlaczek, P; van Dalen, A; Einarsson, R
      Tissue polypeptide specific antigen (TPS), a marker for differentiation between pancreatic carcinoma and chronic pancreatitis - A comparative study with CA 19-9

      CANCER
    45. Halm, U; Schumann, T; Schiefke, I; Witzigmann, H; Mossner, J; Keim, V
      Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survivaltime in patients with advanced pancreatic cancer

      BRITISH JOURNAL OF CANCER
    46. Toki, T; Kubota, J; Lu, X; Nakayama, K
      Immunohistochemical analysis of CA125, CA19-9, and Ki-67 in stage III or IV endometriosis: positive correlation between serum CA125 level and endometriotic epithelial cell proliferation

      ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
    47. Brockmann, J; Glodny, B; Menzel, J; Winde, G; Senninger, N
      Quantificating expression of tumormarkers in gallbladder bile for identification of malignancies of the subhepatic bilio-pancreatic system

      LANGENBECKS ARCHIVES OF SURGERY
    48. Kuroda, N; Hayashi, Y; Nishida, Y; Itoh, H
      Combined small and transitional cell carcinoma of the urinary bladder withCA19-9 production

      PATHOLOGY INTERNATIONAL
    49. Tsuji, M; Kashihara, T; Terada, N; Mori, H
      An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19

      PATHOLOGY INTERNATIONAL
    50. Kau, SY; Shyr, YM; Su, CH; Wu, CW; Lui, WY
      Diagnostic and prognostic values of CA 19-9 and CEA in periampullary cancers

      JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    51. Muramatsu, T; Yasuda, M; Itoh, J; Kamoshida, S; Hirasama, T; Murakami, M; Shinozuka, T; Osamura, RY; Makino, T
      Immunohistochemical characterization of DU-PAN-2 expression in endometrialadenocarcinomas associated with CA19-9 expression

      APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    52. Kamoshida, S; Yasuda, M; Serizawa, A; Muramatsu, T; Shinozuka, T; Makino, T; Osamura, RY
      Immunohistochemical analysis of DU-PAN-2, CA9-9, and Le(a) in normal uterine glands

      APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    53. Rhodes, JM
      Usefulness of novel tumour markers

      ANNALS OF ONCOLOGY
    54. DiMagno, EP
      Pancreatic cancer: Clinical presentation, pitfalls and early clues

      ANNALS OF ONCOLOGY
    55. Ito, S; Gejyo, F
      Elevation of serum CA19-9 levels in benign diseases

      INTERNAL MEDICINE
    56. Kobayashi, I; Kiyoshima, T; Ozeki, S; Shima, K; Shigemura, N; Matsuo, K; Sakai, H
      Immunohistochemical and ultrastructural study of a papillary cystadenocarcinoma arising from the sublingual gland

      JOURNAL OF ORAL PATHOLOGY & MEDICINE
    57. Kudoh, K; Kikuchi, Y; Kita, T; Tode, T; Takano, M; Hirata, J; Mano, Y; Yamamoto, K; Nagata, I
      Preoperative determination of several serum tumor markers in patients withprimary epithelial ovarian carcinoma

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    58. Lo, SST; Khoo, US; Cheng, DKL; Ng, TY; Wong, LC; Ngan, HYS
      Role of serial tumor markers in the surveillance for recurrence in endometrial cancer

      CANCER DETECTION AND PREVENTION
    59. Heinemann, V; Schermuly, MM; Stieber, P; Schulz, L; Jungst, D; Wilkowski, R; Schalhorn, A
      CA19-9: A pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin

      ANTICANCER RESEARCH
    60. Abe, A; Nakano, T; Morita, S; Oka, K
      Clinical evaluation of serum and immunohistochemical expression of SCC andCA19-9 in radiation therapy for cervical cancer

      ANTICANCER RESEARCH
    61. Cerwenka, H; Aigner, R; Bacher, H; Werkgartner, G; El-Shabrawi, A; Quehenberger, F; Mischinger, HJ
      TUM2-PK (pyruvate kinase type tumor M2), CA19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesions

      ANTICANCER RESEARCH
    62. Nagahama, H; Okada, S; Okusaka, T; Ishii, H; Ikeda, M; Nakasuka, H; Yoshimori, M
      Clinicopathological features in misdiagnosed pancreatic carcinoma

      HEPATO-GASTROENTEROLOGY
    63. Hwang, IR; Nahm, DH; Cho, SN; Longenecker, BM; Koganty, RR; Park, IS
      Anti-T antibodies and peanut-agglutinin-binding glycoproteins in sera of patients with gastric cancer

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    64. Theodor, L; Melzer, E; Sologov, M; Idelman, G; Friedman, E; Bar-Meir, S
      Detection of pancreatic carcinoma - Diagnostic value of K-ras mutations incirculating DNA from serum

      DIGESTIVE DISEASES AND SCIENCES
    65. Peterli, R; Meyer-Wyss, B; Herzog, U; Tondelli, P
      CA19-9 useless as a tumour marker in cases with obstructive jaundice

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    66. Ishibashi, R; Sakai, T; Yamashita, Y; Maekawa, T; Hideshima, T; Shirakusa, T
      Benign epithelial cyst of the spleen with a high production of carbohydrate antigen 19-9

      INTERNATIONAL SURGERY
    67. Fujita, J; Dobashi, N; Ohtsuki, Y; Ueda, Y; Bandoh, S; Yamadori, I; Takahara, J
      Detection of large molecular weight cytokeratin 8 as carrier protein of CA19-9 in non-small-cell lung cancer cell lines

      BRITISH JOURNAL OF CANCER
    68. VENTRUCCI M; UBALDUCCI GM; CIPOLLA A; PANELLA MA; LIGABUE A
      SERUM CA-242 - THE SEARCH FOR A VALID MARKER OF PANCREATIC-CANCER

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    69. TOKUCHI Y; UKITA H; TSUNETA Y; NISHIURA Y; TAKAHASHI W; KAWAI T; ISOBE H; KAWAKAMI Y
      BRONCHOGENIC CYST WITH HIGH-CARBOHYDRATE ANTIGEN-19-9 IN THE CYST FLUID AND THE SERUM

      Internal medicine
    70. MERMERSHTAIN W; SEBBAG G; ARIAD S; COHEN Y
      EXTREMELY ELEVATED CA-19-9 SERUM LEVEL IN A PATIENT WITH ACUTE BILIARY OBSTRUCTION AND CHRONIC CHOLECYSTITIS

      Journal of tumor marker oncology
    71. NOUTS A; LEVY P; VOITOT H; BERNADES P
      DIAGNOSTIC-VALUE OF CA-19-9 ANTIGEN IN PA TIENTS WITH CHRONIC-PANCREATITIS OR PANCREATIC ADENOCARCINOMA - EFFECTS OF COMPLICATIONS

      Gastroenterologie clinique et biologique
    72. SAYGILI U; USLU T; ERTEN O; DOGAN E
      BORDERLINE OVARIAN-TUMORS - RETROSPECTIVE ANALYSIS OF 21 CASES

      European journal of gynaecological oncology
    73. OKUSAKA T; OKADA S; SATO T; WAKASUGI H; SAISHO H; FURUSE J; ISHIKAWA O; MATSUNO S; YOKOYAMA S
      TUMOR-MARKERS IN EVALUATING THE RESPONSE TO RADIOTHERAPY IN UNRESECTABLE PANCREATIC-CANCER

      Hepato-gastroenterology
    74. ADACHI Y; ISO Y; MORIYAMA M; KASAI T; HASHIMOTO H
      INCREASED SERUM CA19-9 IN PATIENTS WITH XANTHOGRANULOMATOUS CHOLECYSTITIS

      Hepato-gastroenterology
    75. HIGAKI K; JIMI A; WATANABE J; KUSABA A; KOJIRO M
      EPIDERMOID CYST OF THE SPLEEN WITH CA19-9 OR CARCINOEMBRYONIC ANTIGENPRODUCTIONS - REPORT OF 3 CASES

      The American journal of surgical pathology
    76. ORDONEZ NG
      ROLE OF IMMUNOHISTOCHEMISTRY IN DISTINGUISHING EPITHELIAL PERITONEAL MESOTHELIOMAS FROM PERITONEAL AND OVARIAN SEROUS CARCINOMAS

      The American journal of surgical pathology
    77. DECKER D; BOLLMANN R; HIRNER A; STRATMANN H
      CA 19-9 EXPRESSION OF A SPLENIC CYST

      Zentralblatt fur Chirurgie
    78. AGORRIA AA; PINEIRO FV; HURLE EA; MORELL AR
      CARBOHYDRATE ANTIGEN 195 (CA 195) BEHAVIOR IN THE SERA FROM PATIENTS WITH NON TUMORAL DISEASES

      Medicina Clinica
    79. SOHDA T; IWATA Y; SHIJO H; EGASHIRA Y; EGASHIRA K; OKUMURA M
      INCREASED EXPRESSION OF PROLIFERATING CELL NUCLEAR ANTIGEN IN AUTOIMMUNE HEPATITIS IN A PATIENT WITH RAISED SERUM CONCENTRATION OF CA19-9

      Journal of Clinical Pathology
    80. Nakata, B; Chung, KHYS; Kato, Y; Yamashita, Y; Maeda, K; Onoda, N; Sawada, T; Sowa, M
      Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma

      CANCER
    81. GOGAS H; LOFTS FJ; EVANS TRJ; DARYANANI S; MANSI JL
      ARE SERIAL MEASUREMENTS OF CA19-9 USEFUL IN PREDICTING RESPONSE TO CHEMOTHERAPY IN PATIENTS WITH INOPERABLE ADENOCARCINOMA OF THE PANCREAS

      British Journal of Cancer
    82. DUFFY MJ
      CA-19-9 AS A MARKER FOR GASTROINTESTINAL CANCERS - A REVIEW

      Annals of clinical biochemistry
    83. TAKAMORI S; YOSHIMOTO J; KOJIMA K; MATSUMOTO T; BEPPU T; FUTAGAWA S
      PROGNOSTIC IMPLICATION AND INTRATUMORAL HETEROGENEITY OF P53, KI-67, CEA AND CA19-9 EXPRESSIONS IN CHOLANGIOCELLULAR CARCINOMA

      HEPATOLOGY RESEARCH
    84. SCAPA E; BROIDE E; PINHASOV I
      THE EFFECT OF COLONOSCOPY ON TUMOR-MARKERS

      Surgical laparoscopy & endoscopy
    85. NAKAYAMA T; WATANABE M; TERAMOTO T; KITAJIMA M
      PROGNOSTIC VALUES OF SERUM CA19-9 AND CEA LEVELS FOR COLORECTAL-CANCER

      Oncology Reports
    86. LO SST; CHENG DKL; NG TR; WONG LC; NGAN HYS
      PROGNOSTIC-SIGNIFICANCE OF TUMOR-MARKERS IN ENDOMETRIAL CANCER

      Tumor biology
    87. LEE KC; YAMAZAKI O; HORII K; HAMBA H; HIGAKI I; HIRATA S; INOUE T
      MIRIZZI-SYNDROME CAUSED BY XANTHOGRANULOMATOUS CHOLECYSTITIS - REPORTOF A CASE

      SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY
    88. MORIMOTO K; INOUYE K
      FLOW CYTOMETRIC ANALYSIS OF SIALYL-LEWIS A-ANTIGEN ON HUMAN CANCER-CELLS BY USING F(AB')(2-MU) FRAGMENTS PREPARED FROM A MOUSE IGM MONOCLONAL-ANTIBODY

      Cytotechnology
    89. PECTASIDES D; MYLONAKIS A; KOSTOPOULOU M; PAPADOPOULOU M; TRIANTAFILLIS D; VARTHALITIS J; DIMITRIADES M; ATHANASSIOU A
      CEA, CA-19-9, AND CA-50 IN MONITORING GASTRIC-CARCINOMA

      American journal of clinical oncology
    90. GEBAUER G; MULLERRUCHHOLTZ W
      TUMOR-MARKER CONCENTRATIONS IN NORMAL AND MALIGNANT-TISSUES OF COLORECTAL-CANCER PATIENTS AND THEIR PROGNOSTIC RELEVANCE

      Anticancer research
    91. GEBAUER G; MULLERRUCHHOLTZ W
      TUMOR-MARKER CONCENTRATIONS IN NORMAL AND MALIGNANT-TISSUES OF COLORECTAL-CANCER PATIENTS AND THEIR PROGNOSTIC RELEVANCE

      Anticancer research
    92. NAKAYAMA T; WATANABE M; TERAMOTO T; KITAJIMA M
      SLOPE ANALYSIS OF CA19-9 AND CEA FOR PREDICTING RECURRENCE IN COLORECTAL-CANCER PATIENTS

      Anticancer research
    93. CERWENKA H; AIGNER R; QUEHENBERGER F; WERKGARTNER G; BACHER H; HAUSER H; MISCHINGER HJ
      PREOPERATIVE DIFFERENTIAL-DIAGNOSIS OF BENIGN AND MALIGNANT PANCREATIC LESIONS - THE VALUE OF PANCREATIC SECRETORY TRYPSIN-INHIBITOR, PROCARBOXYPEPTIDASE-B, CA19-9 AND CEA

      Hepato-gastroenterology
    94. ISHII H; OKADA S; SATO T; WAKASUGI H; SAISHO H; FURUSE J; ISHIKAWA O; MATSUNO S; YOKOYAMA S
      CA-19-9 IN EVALUATING THE RESPONSE TO CHEMOTHERAPY IN ADVANCED PANCREATIC-CANCER

      Hepato-gastroenterology
    95. YAMAGUCHI K; NAKAMURA K; YOKOHATA K; SHIMIZU S; CHIJIIWA K; TANAKA M
      PANCREATIC CYST AS A SENTINEL OF IN-SITU CARCINOMA OF THE PANCREAS - REPORT OF 2 CASES

      International journal of pancreatology
    96. WENIG BM; ALBORESSAAVEDRA J; BUETOW PC; HEFFESS CS
      PANCREATIC MUCINOUS CYSTIC NEOPLASM WITH SARCOMATOUS STROMA - A REPORT ON 3 CASES

      The American journal of surgical pathology
    97. YIANNAKOU JY; NEWLAND P; CALDER F; KINGSNORTH AN; RHODES JM
      PROSPECTIVE-STUDY OF CAM 17-CENTER-DOT-1 WGA MUCIN ASSAY FOR SEROLOGICAL DIAGNOSIS OF PANCREATIC-CANCER/

      Lancet
    98. TSURUTA T; OGAWA A; ISHII K; IKADO S
      CA19-9 - A POSSIBLE SERUM MARKER FOR EMBRYONAL CARCINOMA

      Urologia internationalis
    99. TOLLIVER BA; OBRIEN BL
      ELEVATED TUMOR-ASSOCIATED ANTIGEN CA-19-9 IN A PATIENT WITH AN ENLARGED PANCREAS - DOES IT ALWAYS IMPLY MALIGNANCY

      Southern medical journal
    100. INDINNIMEO M; REALE MG; CICCHINI C; STAZI A; FIORI E; IZZO P
      CEA, TPA, CA-19-9, SCC AND CYFRA AT DIAGNOSIS AND IN THE FOLLOW-UP OFANAL-CANAL TUMORS

      International surgery


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/10/20 alle ore 06:09:36